Previously submitted to: iProceedings (no longer under consideration since Jan 09, 2025)
Date Submitted: Oct 27, 2024
Open Peer Review Period: Jan 9, 2025 - Jan 9, 2025
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Digital health diplomacy: Regional and global digital health in a post-pandemic world
ABSTRACT
Digital health is having its moment on the diplomatic stage. Recognising the rapidly accelerating digital transformation of healthcare following COVID-19, the ‘G20 Bali Leaders’ Declaration’ called for “continued international dialogue and collaboration on the establishment of trusted global digital health networks, aligning well with the World Health Organization’s (WHO) advocacy for “more effective public participation and transparency in national and international digital health decision-making processes, such as through international consultation processes or a stakeholder forum”. Recognising MEDINFO 2023 as a prime example of such a ‘trusted global digital health network’ and ‘stakeholder forum’ for ‘international digital health decision-making’, we propose a MEDINFO2023 panel discussion on how 'Digital Health Diplomacy’ (DHD) may serve as a boundary-spanner in this growing field to build functional knowledge bridges between regions and cultures. We will present examples from different international contexts where progress is being made on global projects for digital health services. DHD may help the public understand the value of global digital health services, and inform policy-makers and academics about the diplomacy required to achieve them. Following this panel presentation, we invite the convened global digital health community of digital health professionals, diplomats, political and social scientists, epidemiologists, academics, and clinicians to discuss, critique, and advance the emerging domain of DHD for advancing global digital health.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.